This report provides a comprehensive analysis of AstraZeneca's strategic management and sustainability initiatives. It begins with an introduction to the company and the impact of the COVID-19 pandemic on the pharmaceutical industry. The main body delves into AstraZeneca's internal analysis using Porter's Generic Strategies and Ansoff's Matrix to evaluate its existing business strategies. The report includes a VRIO analysis and SWOT analysis to assess the company's resources, capabilities, strengths, weaknesses, opportunities, and threats. Furthermore, it examines AstraZeneca's implementation of environmental sustainability, market sustainability, business sustainability, and financial sustainability. The report concludes with key findings, recommendations, and references, offering a detailed overview of AstraZeneca's strategic approach and commitment to sustainability.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
